Harvard Apparatus Regenerative Technology amends 8-K to reclassify CEO $300,000 bridge note disclosure under Item 1.01
HRGN•8-K/A corrects classification of bridge note deal
Harvard Apparatus Regenerative Technology filed an 8-K/A to correct its April 15, 2026 8-K classification of a bridge note deal.
The company said the $300,000 Bridge Note with CEO Junli He was a new material definitive agreement, not a termination.
The Bridge Note carries 8% fixed interest, with repayment due at a $5 million-plus capital raise closing or April 13, 2027.
